Antitumor effector CD4+ T cells that respond to specific tumor-antigen stimulation were primed in TDLNs, and the majority of these tumor-specific CD4+ T cells were induced from donor CD4+ T cells (Fig 3C and 3D). Here, CD4 is linked to neoplasm.